{"id":"https://openalex.org/W2052362879","doi":"https://doi.org/10.1097/00004714-198107000-00005","title":"The Dopamine System Challenge in Affective Disorders","display_name":"The Dopamine System Challenge in Affective Disorders","publication_year":1981,"publication_date":"1981-07-01","ids":{"openalex":"https://openalex.org/W2052362879","doi":"https://doi.org/10.1097/00004714-198107000-00005","mag":"2052362879","pmid":"https://pubmed.ncbi.nlm.nih.gov/7028802"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-198107000-00005","doi":"https://doi.org/10.1097/00004714-198107000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-198107000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106182451","display_name":"Thomas R. Insel","orcid":"https://orcid.org/0000-0001-5031-0160","observed_orcids":["https://orcid.org/0000-0001-5031-0160"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"THOMAS R. INSEL","raw_affiliation_strings":["Clinical Neuropharmacology Branch, National Institute of Mental Health, Bethesda, Maryland","Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205","Address requests for reprints to: Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, National Institute of Mental Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Address requests for reprints to: Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647","https://openalex.org/I4210158500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108208490","display_name":"Larry J. Siever","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LARRY J. SIEVER","raw_affiliation_strings":["Clinical Neuropharmacology Branch, National Institute of Mental Health, Bethesda, Maryland","Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205","Address requests for reprints to: Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, National Institute of Mental Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Address requests for reprints to: Thomas R. Insel, MD, Clinical Neuropharmacology Branch, NIMH, NIH Clinical Center, Bldg. 10, Rm. 3D41, Bethesda, MD 20205","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647","https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2731,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.42498438,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"1","issue":"4","first_page":"207","last_page":"213"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7231000065803528,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7231000065803528,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.2517000138759613,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopaminergic-system","display_name":"dopaminergic system","score":0.9520000219345093},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mood-regulation","display_name":"mood regulation","score":0.671999990940094},{"id":"https://openalex.org/keywords/dopaminergic-agents","display_name":"dopaminergic agents","score":0.7599999904632568},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.9139999747276306},{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroendocrine-response","display_name":"neuroendocrine response","score":0.8579999804496765},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.7440000176429749},{"id":"https://openalex.org/keywords/activity-level","display_name":"activity level","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.8370624780654907},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7152081727981567},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.6083584427833557},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5370122194290161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.492241770029068},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4508431553840637},{"id":"https://openalex.org/C2777134132","wikidata":"https://www.wikidata.org/wiki/Q188638","display_name":"Mood disorders","level":3,"score":0.42476382851600647},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3749066889286041},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.37114620208740234},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001519","descriptor_name":"Behavior","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004702","descriptor_name":"Endocrine Glands","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013006","descriptor_name":"Growth Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019964","descriptor_name":"Mood Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-198107000-00005","doi":"https://doi.org/10.1097/00004714-198107000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-198107000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:7028802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7028802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2395241578","https://openalex.org/W2339026227","https://openalex.org/W3091957474","https://openalex.org/W2047136857","https://openalex.org/W2134817776","https://openalex.org/W1491884550","https://openalex.org/W105162121","https://openalex.org/W2061005874","https://openalex.org/W2089602366","https://openalex.org/W2082295647"],"abstract_inverted_index":{"The":[0],"authors":[1],"review":[2],"studies":[3],"of":[4,20,35,73],"dopaminergic":[5,61],"agents":[6,62],"in":[7,32],"affective":[8,47],"disorder":[9,49],"patients.":[10],"Although":[11],"evidence":[12],"from":[13,17,24,53],"cerebrospinal":[14],"fluid":[15],"studies,":[16],"the":[18,21,29,33,60],"pharmacology":[19],"antidepressants,":[22],"and":[23,55,64],"several":[25],"clinical":[26],"trials":[27],"implicates":[28],"dopamine":[30],"system":[31],"regulation":[34],"mood":[36],"or":[37],"activity":[38],"level,":[39],"as":[40],"yet,":[41],"no":[42],"replicated":[43],"study":[44],"shows":[45],"that":[46],"level":[48],"patients":[50],"are":[51,76],"different":[52],"normals":[54],"their":[56],"neuroendocrine":[57,74],"response":[58,75],"to":[59],"L-dopa":[63],"apomorphine.":[65],"Some":[66],"possible":[67],"reasons":[68],"for":[69],"this":[70],"apparent":[71],"normality":[72],"discussed.":[77]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}